Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Analyzing the clinical actionability of germline pharmacogenomic findings in oncology. Cancer. 2018 07 15; 124(14):3052-3065.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Clinical Decision-Making
Drug Prescriptions
Genetic Testing
Genotyping Techniques
Germ-Line Mutation
Humans
Neoplasms
Patient Selection
Pharmacogenetics
Practice Guidelines as Topic
Precision Medicine
Prospective Studies
Treatment Outcome
authors with profiles
Rita Nanda
Blase Polite
Peter H. O'Donnell
Walter M. Stadler
Mark J. Ratain